empty
 
 
05.11.2020 11:52 AM
AstraZeneca has increased its quarterly sales, expects data from COVID-19 vaccine trials this year.

This image is no longer relevant

AstraZeneca is expected to release the highly anticipated results of the third phase of vaccine trials in the coming weeks.

At the same time, the demand for the company's drugs remained high, despite the disruptions in the work of health systems due to the pandemic.

According to the results of the financial report, the company's sales grew by 7% in the quarter ended September 30, and reached $ 6.52 billion. Revenues from co-developed drugs and currency fluctuations were not included in the calculation.

Basic earnings per share were 94 cents per share against the forecast of 98 cents.

At the end of the year, AstraZeneca expects to increase total revenue by 7-13% and increase basic earnings per share by 14-19%.

Thomas Frank,
Pakar analisis InstaForex
© 2007-2025
Ringkasan
Urgensi
Analitik
Thomas Frank
Mulai berdagang
Dapatkan keuntungan dari perubahan nilai mata uang kripto dengan InstaForex.
Unduh MetaTrader 4 dan buka perdagangan pertama Anda.
  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    GABUNG KONTES
  • Chancy Deposit
    Isi akun Anda sebesar $3000 dan dapatkan $6000 lebih banyak!
    Pada Desember kami mengundi $6000 dalam promo Chancy Deposit!
    Dapatkan kesempatan untuk menang dengan melakukan deposit sebesar $3000 pada akun trading Anda. Setelah memenuhi persyaratan ini, Anda telah menjadi partisipan promo.
    GABUNG KONTES
  • Trade Wise, Win Device
    Top up akun anda dengan dana minimal $500, daftar kontes, dan dapatkan peluang untuk memenangkan perangkat seluler.
    GABUNG KONTES
  • 30% Bonus
    Raih bonus 30% setiap kali anda top up
    DAPATKAN BONUS

Artikel yang direkomendasikan

Tidak bisa bicara sekarang?
Tanyakan pertanyaan anda lewat chat.
Widget callback